| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 05/18/2007 | WO2006114105A3 Use of modified factor vii for treating bleeding |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070110785 Medical devices with proteasome inhibitors for the treatment of restenosis |
| 05/15/2007 | US7217414 Methods of preventing peritonitis by administering lactic acid bacterium |
| 05/09/2007 | EP1782849A2 Three-dimensional stromal tissue |
| 05/02/2007 | EP1104323A4 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 04/18/2007 | EP1438976A4 Polyfunctional biocompatible hydrogel and method for the production thereof |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | CN1950396A 抗真菌肽 Antifungal Peptide |
| 04/18/2007 | CN1310672C Osteogenis oligopeptide as blood-formation stimulation articles |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/10/2007 | US7202236 Salts of inhibitors of trypsin-like proteases such as thrombin, e.g., a sulfonate salt of Ph(3-Cl)(5-OCHF2) (R)CH(OH)C(O) (S)Aze-Pab(OMe), combined with a cellulose ether neutral gelling polymer for the treatment or prevention of thrombosis |
| 04/04/2007 | EP1768602A2 Combination drug therapy for reducing scar tissue formation |
| 04/04/2007 | EP1325757B1 Embolic materials |
| 03/28/2007 | CN1306940C Vitreoretinal tamponades based on fluorosilicone fluids |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070065485 Therapeutic delivery of carbon monoxide |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/14/2007 | EP1762248A1 Use of cobalt porphyrins in joint therapy with an immunosuppressant drug for treatment of transplant patients or autoimmune disorders |
| 03/14/2007 | EP1581165B1 Factor viia inhibiting compounds |
| 03/14/2007 | CN1303953C Composition for acceleration of wound and burn healing and wound and burn healing dressing |
| 03/07/2007 | EP1758915A2 Composition and method for inhibiting platelet aggregation |
| 03/07/2007 | CN1923198A Use of kurarinone in preparation of medicine for postoperative intestine functional restoration |
| 03/01/2007 | WO2007024015A1 Material for preventing tissue adhesion and arthrogryposis |
| 03/01/2007 | WO2007022616A2 Hybrid ultrafast laser surgery and growth factor stimulation for ultra-precision surgery with healing |
| 03/01/2007 | WO2006073711A3 Use of a matrix comprising a contrast agent in soft tissues |
| 02/28/2007 | EP1320541B1 Tgf-beta inhibitors and methods |
| 02/21/2007 | CN1917899A Use of alkaline phosphatase for the detoxification of lps |
| 02/21/2007 | CN1917896A Surface protection of exposed biological tissues |
| 02/21/2007 | CN1301139C Biomaterials for preventing post-surgical adhesions comprised of hyaluronic acid derivs. |
| 02/20/2007 | US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 02/20/2007 | US7179788 Synergistic mixtur eof glucangon-like peptide , in solid phase, and insulin solution, in liquid phase; antidiabetic agents; obesity |
| 02/20/2007 | US7179461 Topical applying kinase to eye surface |
| 02/15/2007 | WO2007018226A1 Prophylactic and/or therapeutic agent for corneal disorder |
| 02/15/2007 | US20070037996 4-(N (S-glutathionylacetyl)amino)phenylarsenoxide (GSAO) and derivatives; antiinflammatory and antitumor agents; blood and autoimmune disorders; viral infections; anticoagulants |
| 02/15/2007 | US20070037995 A Substantially Cell Membrane Impermeable Compound And Use Thereof |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1169069B1 Use of three-dimensional stromal tissue for the treatment of ischemic tissue |
| 02/14/2007 | CN1913893A NK-1 receptor antagonists for improving anesthesia recovery |
| 02/14/2007 | CN1911438A 血管新生诱导剂 Angiogenic inducer |
| 02/14/2007 | CN1911422A Traditional Chinese medicine composition for treating adenomyosis uteri |
| 02/08/2007 | US20070033668 Inbred miniature swine and uses thereof |
| 02/06/2007 | CA2331672C Dextrin-containing composition for preventing surgical adhesions |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/25/2007 | WO2007010858A1 Pluripotent stem cell cloned from single cell derived from skeletal muscle tissue |
| 01/24/2007 | EP1744746A2 Use of melatonin in preventing postoperative complications |
| 01/24/2007 | CN1899265A Medical dust cloud agent or granular agent and its use |
| 01/17/2007 | CN1895267A Composite gel of CMC and collagen synthase inhibitor for preventing adhered Fe crosslinked and its preparation |
| 01/16/2007 | US7163930 Pharmaceutical compositions and methods relating to fucans |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | DE102005030614A1 Zellfreies Transplantat Cell-free graft |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | CN1889974A Oligopeptides as coating material for medical products |
| 12/28/2006 | WO2006137546A1 Treatment method for preventing transplantation tissue with biological origin from calcification and tissue treated thereby |
| 12/28/2006 | WO2006137341A1 Agent for visualizing vitreous body |
| 12/28/2006 | US20060293351 Promotion of wound healing |
| 12/28/2006 | US20060293254 Podophyllotoxin |
| 12/28/2006 | CA2613244A1 Vitreous body visualization agent |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1734821A2 Activators of hexosamine biosynthesis as inhibitors of injury induced by ischemia or hemorrhagic shock |
| 12/27/2006 | EP1173255B1 Use of pirenoxine for the protection of corneal tissues in photokeratectomy |
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/21/2006 | US20060287689 Cochlear implant drug delivery device |
| 12/20/2006 | EP1732486A1 Drug-enhanced adhesion prevention |
| 12/20/2006 | EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 12/20/2006 | EP1276488B1 Use of lactic acid bacterium for the prevention of peritonitis |
| 12/20/2006 | CN1290907C A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 12/20/2006 | CN1290869C Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 12/20/2006 | CN1290586C A haemostatic kit, a method of preparing a haemostatic agent |
| 12/19/2006 | CA2232880C Semi-fluorinated alkanes and their use |
| 12/14/2006 | WO2006132310A1 Liquid for preventing tissue adhesion and method of preventing tissue adhesion |
| 12/14/2006 | WO2006132204A1 Transcription factor decoy |
| 12/14/2006 | CA2614295A1 Transcription factor decoy |
| 12/13/2006 | EP1730180A1 Antifungal peptides |
| 12/13/2006 | EP1482975B1 Prevention of tissue adhesion |
| 12/12/2006 | CA2242618C Compositions comprising ultrapure pvp having an average molecular weight in the range of 7,000 to 12,000 daltons |
| 12/07/2006 | US20060276524 2-(2,5-Dioxoimidazolidin-4-yl)-N-[2-(4'-fluoro-biphenyl-4-yl)-ethyl]-acetamide; asthma, chronic obstructive pulmonary disease, arthritis, atherosclerosis, restenosis; potent and highly selective inhibitors |
| 12/07/2006 | US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation |
| 12/06/2006 | EP1210086B1 Use of halofuginone for treating urethral stricture |
| 11/30/2006 | WO2006127907A2 Localized delivery of cardiac inotropic agents |
| 11/30/2006 | CA2609456A1 Localized delivery of cardiac inotropic agents |
| 11/29/2006 | EP1725243A2 Boronate medicaments for preventing thrombosis during surgery |
| 11/29/2006 | EP1725242A2 Boronate medicaments suitable for short duration anticoagulation |
| 11/29/2006 | EP1299039B1 Surgical high pressure liquid jet device with liquid medicament |
| 11/28/2006 | US7142910 Methods of indirectly stimulating the vagus nerve with an electrical field |
| 11/28/2006 | US7141716 Major histocompatibility complex; transgenic swine |
| 11/28/2006 | US7141580 activity as prostaglandin E2 receptor antagonists |
| 11/22/2006 | EP1723959A1 Composition comprising platelet-rich plasma |
| 11/21/2006 | US7138530 for inhibiting the enzyme C1s, a protease in the classical pathway of the complement system; and the use of this inhibition to treat or ameliorate acute or chronic disorders in mammals |
| 11/21/2006 | CA2327693C Use of phospholipids for the manufacture of a medicament for the prevention of adhesions |
| 11/16/2006 | US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders |
| 11/15/2006 | EP1572175B1 Formulation, which can be administered gastrointestinally, containing green tea extract and an no donor |
| 11/14/2006 | US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis |
| 11/08/2006 | EP1719522A1 Medicinal composition comprising TCF-II |
| 11/08/2006 | CN1857235A Absorbable medical film |
| 11/07/2006 | US7132434 N-[(3S)-1-hydroxy-2-oxopyrrolidinyl]-N-methyl-4'-(trifluoromethyl)[1,1'-biphenyl]-4-sulfonamide or derivatives to treat Respiratory system disorders; arthritis, and bone disorders |